Citadel Advisors’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-168,272
Closed -$65K 11031
2020
Q1
$65K Buy
168,272
+66,143
+65% +$23.9K ﹤0.01% 8903
2019
Q4
$42K Buy
+102,129
New +$170K ﹤0.01% 8802
2019
Q3
Sell
-25,391
Closed -$51.4K 10195
2019
Q2
$55K Buy
25,391
+8,177
+48% +$20.9K ﹤0.01% 8703
2019
Q1
$54K Buy
17,214
+2,015
+13% +$6.52K ﹤0.01% 8795
2018
Q4
$38K Buy
15,199
+2,194
+17% +$7.3K ﹤0.01% 8557
2018
Q3
$52K Buy
+13,005
New +$57.3K ﹤0.01% 8801
2017
Q4
Sell
-16,339
Closed -$35K 8795
2017
Q3
$35K Sell
16,339
-2,768
-14% -$9.42K ﹤0.01% 7261
2017
Q2
$86K Buy
19,107
+4,971
+35% +$18K ﹤0.01% 6958
2017
Q1
$42K Sell
14,136
-14,172
-50% -$41.8K ﹤0.01% 7091
2016
Q4
$78K Buy
28,308
+3,969
+16% +$11.3K ﹤0.01% 6761
2016
Q3
$76K Buy
24,339
+8,262
+51% +$30.1K ﹤0.01% 6743
2016
Q2
$82K Buy
+16,077
New +$77.3K ﹤0.01% 6275
2016
Q1
Sell
-11,598
Closed -$94K 8613
2015
Q4
$94K Buy
11,598
+3,956
+52% +$33K ﹤0.01% 6766
2015
Q3
$64K Sell
7,642
-10,390
-58% -$95.7K ﹤0.01% 7401
2015
Q2
$170K Buy
18,032
+12,896
+251% +$120K ﹤0.01% 6516
2015
Q1
$48K Buy
5,136
+1,095
+27% +$10.5K ﹤0.01% 7413
2014
Q4
$37K Buy
+4,041
New +$34K ﹤0.01% 7417
2014
Q3
Sell
-11,086
Closed -$80.7K 8591
2014
Q2
$87K Sell
11,086
-11,443
-51% -$86.4K ﹤0.01% 6341
2014
Q1
$178K Buy
22,529
+8,088
+56% +$65.1K ﹤0.01% 5632
2013
Q4
$90K Buy
14,441
+3,659
+34% +$19.2K ﹤0.01% 5694
2013
Q3
$38K Buy
10,782
+4,918
+84% +$11.2K ﹤0.01% 5935
2013
Q2
$11K Buy
+5,864
New +$11.8K ﹤0.01% 6222